Literature DB >> 33314622

Alveolar epithelial cell-derived Sonic hedgehog promotes pulmonary fibrosis through OPN-dependent alternative macrophage activation.

Jiwei Hou1,2, Jie Ji1,2, Xiang Chen1,2, Honghui Cao1,2, Yi Tan1,2, Yu Cui1,2, Zou Xiang3, Xiaodong Han1,2.   

Abstract

The alternative activation of macrophages in the lungs has been considered as a major factor promoting pulmonary fibrogenesis; however, the mechanisms underlying this phenomenon are still elusive. In this study, we investigated the interaction between macrophages and fibrosis-associated alveolar epithelial cells using a bleomycin-induced mouse pulmonary fibrosis model and a coculture system. We demonstrated that fibrosis-promoting macrophages are spatially proximate to alveolar type II (ATII) cells, permissive for paracrine-induced macrophage polarization. Importantly, we revealed that fibrosis-associated ATII cells secrete Sonic hedgehog (Shh), a hedgehog pathway ligand, and that ATII cell-derived Shh promotes the development of pulmonary fibrosis by osteopontin (OPN)-mediated macrophage alternative activation. Mechanistically, Shh promotes the secretion of OPN in macrophages via Shh/Gli signaling cascade. The secreted OPN acts on the surrounding macrophages in an autocrine or paracrine manner and induces macrophage alternative activation through activating the JAK2/STAT3 signaling pathway. Tissue samples from idiopathic pulmonary fibrosis patients confirmed the increased expression of Shh and OPN in ATII cells and macrophages, respectively. Together, our study illustrated an alveolar epithelium-dependent mechanism for macrophage M2 polarization and pulmonary fibrogenesis and suggested that targeting Shh may offer a selective and efficient therapeutic strategy for the development and progression of pulmonary fibrosis.
© 2020 Federation of European Biochemical Societies.

Entities:  

Keywords:  Sonic hedgehog; alveolar type II cells; idiopathic pulmonary fibrosis; macrophage alternative activation; osteopontin

Year:  2020        PMID: 33314622     DOI: 10.1111/febs.15669

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  7 in total

Review 1.  Alveolar Epithelial Type 2 Cell Dysfunction in Idiopathic Pulmonary Fibrosis.

Authors:  Weiwei Zhu; Chunting Tan; Jie Zhang
Journal:  Lung       Date:  2022-09-22       Impact factor: 3.777

2.  The identification and validation of hub genes associated with advanced IPF by weighted gene co-expression network analysis.

Authors:  Lingyi Liu; Yanru Yang; Xin Han; Jiwei Hou
Journal:  Funct Integr Genomics       Date:  2022-09-15       Impact factor: 3.674

3.  Dichotomous Roles of Men1 in Macrophages and Fibroblasts in Bleomycin-Induced Pulmonary Fibrosis.

Authors:  Yuanhua Lu; Jianan Zhao; Yafei Tian; Dan Shao; Zhiqi Zhang; Siqi Li; Jialin Li; Hugang Zhang; Wei Wang; Ping Jiao; Jie Ma
Journal:  Int J Mol Sci       Date:  2022-05-11       Impact factor: 6.208

4.  Mesenchymal Stem Cell-Derived Exosomes Induced by IL-1β Attenuate Urethral Stricture Through Let-7c/PAK1/NF-κB-Regulated Macrophage M2 Polarization.

Authors:  Ye-Hui Chen; Ru-Nan Dong; Jian Hou; Ting-Ting Lin; Shao-Hao Chen; Hang Chen; Jun-Ming Zhu; Jia-Yin Chen; Zhi-Bin Ke; Fei Lin; Xue-Yi Xue; Yong Wei; Ning Xu
Journal:  J Inflamm Res       Date:  2021-07-13

Review 5.  The Hedgehog Signaling Pathway in Idiopathic Pulmonary Fibrosis: Resurrection Time.

Authors:  Wiwin Is Effendi; Tatsuya Nagano
Journal:  Int J Mol Sci       Date:  2021-12-24       Impact factor: 5.923

6.  C/EBP homologous protein promotes Sonic Hedgehog secretion from type II alveolar epithelial cells and activates Hedgehog signaling pathway of fibroblast in pulmonary fibrosis.

Authors:  Xiaoyu Yang; Wei Sun; Xiaoyan Jing; Qian Zhang; Hui Huang; Zuojun Xu
Journal:  Respir Res       Date:  2022-04-08

Review 7.  The Role of Osteopontin in Tumor Progression Through Tumor-Associated Macrophages.

Authors:  Yuying Tan; Lei Zhao; Yong-Guang Yang; Wentao Liu
Journal:  Front Oncol       Date:  2022-07-08       Impact factor: 5.738

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.